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Abstract: Background: Data regarding cardiac remodeling in patients with alcoholic liver cirrhosis
are scarce. We sought to investigate right atrial (RA) and right ventricular (RV) structure, function,
and mechanics in patients with alcoholic liver cirrhosis. Methods: This retrospective cross-sectional
investigation included 67 end-stage cirrhotic patients, who were referred for evaluation for liver
transplantation and 36 healthy controls. All participants underwent echocardiographic examination
including strain analysis, which was performed oﬄine. Results: RV basal diameter and RV thickness
were significantly higher in patients with cirrhosis. Conventional parameters of the RV systolic function
were similar between the observed groups. Global, endocardial, and epicardial RV longitudinal
strains were significantly lower in patients with cirrhosis. Active RA function was significantly higher
in cirrhotic patients than in controls. The RA reservoir and conduit strains were significantly lower
in cirrhotic patients, while there was no difference in the RA contractile strain. Early diastolic and
systolic RA strain rates were significantly lower in cirrhotic patients than in controls, whereas there
was no difference in the RA late diastolic strain rate between the two groups. Transaminases and
bilirubin correlated negatively with RV global longitudinal strain and RV-free wall strain in patients
with end-stage liver cirrhosis. The Model for End-stage Liver Disease (MELD) score, predictor
of 3-month mortality, correlated with parameters of RV structure and systolic function, and RA
active function in patients with end-stage liver cirrhosis. Conclusions: RA and RV remodeling is
present in patients with end-stage liver cirrhosis even though RV systolic function is preserved. Liver
enzymes, bilirubin, and the MELD score correlated with RV and RA remodeling.
Keywords: cirrhosis; right atrium; right ventricle; function; strain
1. Introduction
One decade ago, the term “cirrhotic cardiomyopathy” was first introduced, which usually refers
to the left ventricular (LV) diastolic dysfunction, an inadequate LV response to the stress or prolonged
QT interval, in the absence of known cardiac disease [1,2]. Most studies have been focused on LV
functional remodeling and particularly LV diastolic dysfunction, which was usually determined by
tissue Doppler [3,4]. In the meantime, new echocardiographic techniques that are able to detect
subtle and subclinical changes in cardiac mechanics appeared. One of these new techniques is
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speckle-tracking imaging that enables determination of detailed myocardial mechanics during the
whole cardiac cycle. Investigations showed important predictive value of both LV and right ventricular
(RV) strains in patients with different pathologies [5–7].
There are only a few studies that investigated cardiac remodeling in cirrhotic patients, subjects
with non-alcoholic fatty liver disease, or liver cirrhosis using strain analysis [4,8–10]. Data regarding
an RV strain in the patients with liver cirrhosis are scarce [11]. There is no data regarding RV
layer-specific changes and right atrial (RA) phasic function in the patients with end-stage liver cirrhosis.
The majority of studies showed that RV function, assessed by conventional echocardiographic
parameters, was preserved [4,8,9]. Nevertheless, the large number of patients with cirrhosis has
symptoms of RV dysfunction. Therefore, we hypothesized that new echocardiographic parameters of
RV dysfunction such as global and layer-specific strain could provide insight information regarding
RV function and mechanics.
The aim of the present study was to evaluate RV structure, function, and mechanics, as well
as RA phasic function, in patients who were in the terminal stage of liver cirrhosis. Additionally,
we investigated the correlation between liver enzymes and Model for End-stage Liver Disease (MELD)
score and echocardiographic parameters of RV and RA remodeling.
2. Methodology
This retrospective cross-sectional study included 103 participants: 67 patients with alcoholic
liver cirrhosis preparing for liver transplantation and 36 control subjects of similar age and gender
distribution. Cirrhosis patients were recruited from the department for liver transplantation between
January 2012 and June 2015 and all patients underwent liver transplantation. Exclusion criteria
were heart failure, coronary artery disease, atrial fibrillation, congenital heart disease, more than
mild valvular heart disease, neoplastic disease, and renal failure. Controls were recruited from
the echocardiography department at the same period among the patients who were referred to for
a regular check-up examination, palpitations, or an innocent heart murmur. All subjects underwent
echocardiographic examinations and analyses of obtained data were performed oﬄine. The investigator
who performed the analyses was blinded for groups. Subjects with inadequate echocardiographic
images were excluded from the study (8 patients and 5 controls). The MELD score was calculated for
cirrhotic patients that included creatinine, bilirubin, the International Normalized Ratio (INR), sodium,
and information regarding hemodialysis (at least twice in the last week).
Anthropometric measures (height, weight) and laboratory analyses (liver enzymes, total bilirubin
level, and creatinine level) were taken from all the study subjects. The body mass index (BMI) and
body surface area (BSA) were calculated for each subject. BSA was calculated according to the formula:
(height (cm) * weight (kg)/3600)−1/2. The study was approved by the local Ethics Committee.
2.1. Echocardiography
Echocardiographic examinations were performed using Vivid 7 ultrasound (GE Vingmed, Horten,
Norway).
The RV internal diameter was determined in the basal RV segment in apical four-chamber view [12].
Linear measurement of RV-free wall thickness was performed in four-chamber subcostal view at 2DE
zoomed image at end-diastole, below the tricuspid annulus at a distance approximating the length of
the anterior tricuspid leaflet [12].
Tissue Doppler velocity during systole (st) was evaluated in the apical four-chamber view [12].
Tricuspid annular plane systolic excursion (TAPSE) has been measured in all participants, according to
the guidelines [12]. Fractional area change was calculated as the difference between RV end-diastolic
and end-systolic area divided with the RV end-diastolic area [12]. RV systolic blood pressure (PASP)
was measured in the patients with tricuspid regurgitation.
J. Clin. Med. 2019, 8, 1285 3 of 9
2.2. Right Ventricular Strain
2D strain imaging was performed by using three consecutive cardiac cycles in the apical
four-chamber view that was focused on the RV [13]. EchoPAC 201 software (GE-Healthcare,
Horten, Norway) was used for the 2D strain analysis.
The automatic tracking of the endocardial contour was performed in end-systole and it was
carefully verified. The region of interest was manually corrected to ensure optimal tracking and
inclusion of the entire RV thickness including endocardial, mid-myocardial, and epicardial layers.
After delineating the region of interest, software allowed the investigation of three myocardial layers:
endocardial, mid-myocardial, and epicardial. However, it is assumed that the mid-myocardial layer is
equal to the global RV strain.
2.3. Right Atrium
RA volume was calculated by the single plane Simpson’s method of disks in apical four-chamber
view. RA volumes (RAVs) were measured in three different sequences of the cardiac cycle. Maximal
RAV was measured just before the tricuspid valve opening. In addition, pre-A RAV (pre-atrial
contraction) was determined at the onset of atrial systole (peak of P wave in ECG), whereas minimal
RAV was measured at the tricuspid valve closure. RA volumes were indexed for BSA and RAV indexes
(RAVIs) were calculated for each study participant. The total emptying volume, which represents the
RA reservoir function, was calculated as the difference between maximum and minimum RAV. Passive
emptying volume, which represents the conduit function, was calculated as the difference between
maximum and pre-A RAV, and active emptying volume, which corresponds to RA booster function,
was calculated as the difference between pre-A and minimum RAV. Accordingly, total emptying
fraction (EF) was calculated as the ratio between total emptying volume and maximum RAV. Passive
EF was computed as the ratio between passive and maximum, and active EF was calculated as the
proportion between active and pre-A RAV.
2D strain imaging was performed in the apical four-chamber apical view [14] and using
commercially available software Echo PAC 201 (GE-Healthcare, Horten, Norway) was used for
the 2D strain analysis. The RA strain was calculated using R-R gating. The RA endocardium was
manually traced. Two peaks of RA strain corresponded to reservoir function (first peak between R
wave and T wave) and atrial contractile function (starting on the P wave). The difference between the
reservoir strain and atrial contractile strain values reflects the conduit function.
2.4. Statistical Analysis
Continuous variables were presented as mean ± standard deviation (SD), and the Student t-test
was used to detect differences between the two groups when variables showed normal distribution,
whereas the Mann-Whitney U test was used when they showed non-normal distribution. Differences
in proportions were compared by using the χ2. Spearman’s correlation coefficient was used for
determining the correlation between different clinical and echocardiographic parameters in the patients
with end-stage alcoholic liver cirrhosis. The inter-observer and intra-observer agreements were
determined by evaluating the intra-class correlation coefficients (ICC) in 15 randomly chosen subjects.
The p < 0.05 was considered statistically significant.
3. Results
Patients with cirrhosis were older than controls, whereas there was no difference in sex distribution
and BMI between two groups (Table 1). As expected, all liver enzymes and bilirubin were significantly
higher in cirrhosis patients than in controls.
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Table 1. Demographic and clinical parameters of the study population.
Controls (n = 36) Cirrhosis (n = 67) p
Age (years) 47 ± 13 53 ± 12 0.039
Male (%) 16 (44) 33 (49) 0.683
BMI (kg/m2) 24.9 ± 3.8 26 ± 7.0 0.282
ALT (U/L) 25 ± 10 58 ± 45 <0.001
AST (U/L) 29 ± 15 80 ± 60 <0.001
AP (U/L) 66 ± 18 220 ± 180 0.001
GGT (U/L) 22 ± 12 128 ± 100 0.003
Creatinine (mg/dL) 0.80 ± 0.16 0.98 ± 0.55 0.056
Bilirubin (mg/dL) 0.5 ± 0.3 6.1 ± 8.4 <0.001
MELD 0.71 ± 1.2 13.5 ± 8.9 <0.001
ALT—alanine transaminase. AP—alkaline phosphatases. AST—aspartate transaminase. BMI—body mass index.
GGT—gamma-glutamyl transferase. MELD—model for end-stage liver disease.
3.1. Echocardiography
The RV basal diameter and RV thickness were significantly higher in patients with cirrhosis
(Table 2). There was no difference in RV end-systolic and end-diastolic areas. Parameters of RV systolic
function (TAPSE, FAC, s’) were similar between the observed groups (Table 2). Systolic pulmonary
artery pressure (PAP) was significantly higher in patients with cirrhosis. Vena cava inferior diameter
was similar between the observed groups.
Table 2. Echocardiographic parameters of the study population.
Controls (n = 36) Cirrhosis (n = 67) p
Right ventricle
RV basal diameter (mm) 36 ± 6.8 39 ± 7.3 0.029
RV thickness (mm) 4.4 ± 0.8 5.0 ± 1.0 0.023
RV EDA (cm2) 17.6 ± 4.3 19.0 ± 5.2 0.171
RV ESA (cm2) 9.4 ± 2.7 9.7 ± 2.5 0.596
FAC (%) 47 ± 8 48 ± 10 0.483
TAPSE (mm) 25 ± 4 25 ± 5 0.809
st (cm/s) 13 ± 2.6 14 ± 2.8 0.597
PAPs (mmHg) 22 ± 5 27 ± 8 0.025
IVC (mm) 15 ± 3 17 ± 4 0.160
Right ventricular strain (%)
RV global (%) 21.8 ± 1.7 19.8 ± 4.2 0.005
RV free wall (%) 26.5 ± 3.1 23.4 ± 5.9 0.004
RV longitudinal multilayer strain for the whole ventricle (%)
Endocardial 25.0 ± 2.1 23.0 ± 4.8 0.020
Epicardial 19.3 ± 2.0 17.4 ± 4.3 0.010
EDA—end-diastolic area. ESA—end-systolic area. FAC—fractional area change. IVC—vena cava inferior.
PAPs—systolic pulmonary pressure. RV—right ventricle. s’—systolic flow velocity across the lateral segment of
tricuspid annulus. TAPSE-tricuspid annular plane systolic excursion.
Global, endocardial, and epicardial RV longitudinal strains were significantly lower in patients
with cirrhosis (Table 2). The same results were found for the whole RV and RV-free wall.
3.2. RA Parameters
RA maximal area and volume index were significantly higher in cirrhosis patients (Table 3).
Minimal and pre-A RAVIs were similar between controls and cirrhotic patients. Total and passive RA
emptying fraction (RAEF) did not significantly differ between the observed groups, whereas active
RAEF was significantly higher in cirrhotic patients than in controls (Table 3).
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Table 3. Right atrial parameters in the study population.
Controls (n = 36) Cirrhosis (n = 67) p
RA volume analysis
RAA (cm2) 13 ± 3.3 16 ± 4.8 0.001
RAVImax (mL/m2) 17.2 ± 6.6 23.0 ± 10.2 0.005
RAVImin (mL/m2) 8.3 ± 3.9 10.0 ± 6.1 0.093
RAVIpre-a (mL/m2) 11.2 ± 5.2 13.9 ± 7.2 0.076
RA TotEF (%) 52 ± 12 57 ± 14 0.063
RA PassEF (%) 35 ± 18 35 ± 18 0.882
RA ActEF (%) 26 ± 13 33 ± 16 0.022
RA strain analysis
RA reservoir strain (%) 46 ± 10 39 ± 18 0.020
RA conduit strain (%) 27 ± 8 20 ± 10 <0.001
RA contractile strain (%) 19 ± 7 19 ± 11 0.964
RA early diastolic strain rate (1/s) −1.5 ± 0.7 −1.1 ± 0.7 0.003
RA late diastolic strain rate (1/s) −2.4 ± 1.1 −2.1 ± 1.1 0.155
RA systolic strain rate (1/s) 2.1 ± 0.5 1.8 ± 0.8 0.045
BSA—body surface area. EF—emptying fraction. RA—right atrium. RAVI—right atrial volume index.
The RA reservoir and conduit strains were significantly lower in cirrhotic patients, while there
was no difference in RA contractile strain (Table 3). Early diastolic and systolic RA strain rates were
significantly lower in cirrhotic patients than in controls, whereas there was no difference in the RA late
diastolic strain rate between two groups (Table 3).
3.3. Correlation Analysis
AST, ALT, AP, and bilirubin correlated negatively with the RV global longitudinal strain and
the RV-free wall strain in patients with end-stage liver cirrhosis (Table 4). ALT correlated with the
RA reservoir strain (Table 4). GGT correlated with PAP, the RA reservoir, and contractile strains.
Bilirubin also correlated with the RA contractile strain (Table 4). The MELD score correlated with the
RV basal diameter, TAPSE, s’, PAP, and RA active emptying fraction in patients with end-stage liver
cirrhosis (Table 4).











r r r r r r
RV basal diameter (mm) 0.101 −0.008 −0.014 0.100 0.143 0.268 *
RV thickness (mm) 0.007 0.186 −0.037 −0.142 0.077 0.079
TAPSE (mm) 0.228 0.116 −0.145 −0.212 0.246 0.357 *
st (cm/s) 0.089 0.048 −0.068 −0.234 0.106 0.375 *
FAC (%) 0.106 0.087 0.162 −0.075 0.214 0.183
PAPs (mmHg) 0.016 0.077 −0.032 −0.325 * 0.237 0.345 *
RV global longitudinal strain (%) −0.310 * −0.303 * −0.374 * 0.016 −0.371 * −0.228
RV free wall longitudinal strain (%) −0.333 * −0.325 * −0.353 * 0.041 −0.360 * −0.202
RA TotEF (%) 0.026 0.083 0.044 −0.065 −0.039 −0.076
RA PassEF (%) 0.060 −0.049 0.077 0.084 0.032 0.093
RA ActEF (%) −0.026 0.122 0.028 −0.135 −0.088 −0.261 *
RA reservoir strain (%) 0.114 −0.243 * −0.055 −0.273 * 0.179 0.047
RA conduit strain (%) 0.076 0.196 −0.043 −0.178 0.098 0.036
RA contractile strain (%) 0.089 0.188 −0.011 −0.285 * 0.174 * 0.018
*—p < 0.05. ALT—alanine transaminase. AP—alkaline phosphatases. AST—aspartate transaminase. BMI—body
mass index. EF—emptying fraction. FAC—fractional area change. GGT—gamma-glutamyl transferase.
MELD—model for end-stage liver disease. IVC—vena cava inferior. PAPs—systolic pulmonary pressure.
RA—right atrium. RV—right ventricle. s’—systolic flow velocity across the lateral segment of tricuspid annulus.
TAPSE—tricuspid annular plane systolic excursion.
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3.4. Intra-Observer Variability
The intra-observer variability was high for RV global longitudinal strain: ICC = 0.91 (95%CI: 0.89–0.96,
p < 0.001) as well as for RV global subendocardial longitudinal strain: ICC = 0.93 (95%CI: 0.87–0.97,
p < 0.001). RV global subepicardial longitudinal strain: ICC = 0.84 (95%CI: 0.77–0.95, p < 0.001).
3.5. Inter-Observer Variability
The inter-observer variability was high for RV global longitudinal strain: ICC = 0.89 (95%CI:
0.84–0.95, p < 0.001). RV global subendocardial longitudinal strain: ICC = 0.90 (95%CI: 0.85–0.97,
p < 0.001). RV global subepicardial longitudinal strain: ICC = 0.79 (95%CI: 0.71–0.89, p < 0.001).
4. Discussion
The present study revealed several important findings: (i) RV mechanics was impaired in patients
with end-stage liver cirrhosis. (ii) All myocardial layers were affected in cirrhotic patients. (iii) RA
phasic function was deteriorated in patients with cirrhosis when compared with controls. (iv) MELD
score, as an important predictor of three-month mortality in patients with liver cirrhosis, correlated
with parameters of RV remodeling and RA phasic function in cirrhotic patients.
RV global longitudinal strain, as well as endocardial and epicardial strains, was significantly
lower in cirrhotic patients than in controls. The same results were obtained for the whole RV and
RV-free wall. Reduced RV strain was also found in other investigations that included patients with
cirrhosis or even patients with non-alcoholic fatty liver disease [11,15,16]. However, this is the first
study that showed layer-specific changes in the RV strain in patients with end-stage liver cirrhosis.
It must be emphasized that RV was larger and thicker in cirrhotic patients than in healthy controls,
which potentially could contribute to the RV strain reduction in these patients. Rimbas et al. also
found larger RV in cirrhotic patients than in controls, but the RV global longitudinal strain was still
similar between patients and controls [11]. We did not find any difference in parameters of RV systolic
function (TAPSE, FAC, s’) between patients and controls. Rimbas et al. agree with our results regarding
RV systolic function in cirrhotic patients [11]. On the other hand, Sunbul et al. found significantly
lower TAPSE and s’ in patients with non-alcoholic fatty liver disease [16].
Our findings indicate that all RV myocardial layers are equally affected in patients with cirrhosis.
This represents a new finding that has not been previously investigated. The structure of the RV and
number of layers in its wall is still a topic of debate. There is a lack of agreement if the RV wall consists
of two or three layers. However, studies performed on the LV clearly showed that remodeling usually
begins with endocardium, spreads on the mid-myocardium, and ends in the epicardial layer [17].
This pattern was first discovered in ischemic heart disease, but it seems that this pattern of myocardial
impairment persists in other diseases such as arterial hypertension or diabetes [18,19]. Our study group
showed that all RV myocardial layers were equally affected in patients with arterial hypertension and
diabetes [20]. In the current study, we obtained similar results for cirrhotic patients.
The present study showed that the RA phasic function was deteriorated in the patients in end-stage
alcohol cirrhosis than in healthy controls. Different results were obtained using volumetric and strain
analysis of the RA phasic function. Namely, volumetric RA analysis showed no statistically important
difference in the RA reservoir and conduit functions between patients and controls, whereas the RA
contractile function was significantly higher in cirrhotic patients. Strain analysis showed significantly
lower RA reservoir and conduit functions in cirrhotic patients and no difference in RA contractile
function. Previous studies performed in the same or similar groups of patients did not assess the RA
phasic function. It seems that strain analysis was more sensitive for detecting subtle changes in the
RA phasic function in patients with cirrhosis. This is supported by the fact that more correlations
were found between the strain-derived RA phasic function and liver enzymes than between the
volumetric-derived RA phasic function and liver enzymes. This finding was important from a clinical
point of view because volumetric RA phasic analysis is time consuming, whereas RA strain analysis is
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rapid analysis that provides all required parameters simultaneously. However, it must be emphasized
that commercial software dedicated for RA strain analysis still does not exist and all available data
were obtained using software dedicated for LV strain analysis.
RA dilatation and phasic function impairment have several important clinical implications. RA
dilatation is associated with higher risk of atrial fibrillation recurrence than left atrial dilatation [21] as
well as higher mortality risk in patients with pulmonary hypertension, pulmonary embolism, and heart
failure [22]. Some authors showed that the RA strain represented a good noninvasive method for
pulmonary hemodynamics assessment [23]. This could be important in patients with cirrhosis who
had increased pulmonary pressure in the present study. However, one should be cautious in the
interpretation of these results because not all investigations agree about the relationship between
echocardiographic and hemodynamic evaluation of pulmonary pressure.
There are several possible mechanisms that could explain a reduced RV strain and impaired
RA phasic function in cirrhotic patients. RV and RA strain changes are strongly associated with
other parameters of right heart remodeling such as dilatation of the right heart, RV hypertrophy,
and increased pulmonary pressure. However, it should be emphasized that neither of these
structural, functional, or strain parameters reached pathological values, but they were deteriorated
in comparison with healthy controls. Desensitization of β-adrenergic receptor, higher production
of nitric oxide and carbon monoxide, increased concentration of inflammatory parameters such as
interleukin-8, Interleukin-6, Interleukin-1b, TNF- α, and transforming growth factor- β are possible
mechanisms that could explain impaired cardiac function in liver cirrhosis. Retention of salt and water,
characteristic for cirrhosis, induces the activation of the renin-angiotensin-aldosterone system, which
further provokes cardiac remodeling-cardiac hypertrophy, intramyocardial fibrosis, and fibrosis of
intramyocardial arteries [24,25].
The most important clinical implication of this study is the necessity for more detailed
echocardiographic assessment of the right heart in patients with liver cirrhosis. This particularly
refers to the evaluation of RV and RA strain, which is currently not part of routine examination.
The strain analysis is the rapid method that provides very useful information regarding RV and
RA function and mechanics in a few minutes and it is important in situations when conventional
echocardiographic parameters failed to show right heart impairment, which occurs often in cirrhotic
patients, as demonstrated in our study. A recent study showed that increased RV afterload was related
with increased hemodynamic complications and worse long-term survival after liver transplantation
in the patients with end stage cirrhosis [26]. RV failure can lead to systemic hypoperfusion and
splanchnic congestion, which both contribute to worse patient and graft outcomes. These are the
reasons why the right heart function has a pivotal role in the prognosis of liver transplantation.
5. Limitations
Our study has several limitations. Sample size was limited and statistical significance was not
reached in some important comparisons, even though we found a clear trend toward a significant
difference. Moreover, this was a retrospective study and the echocardiographic exams were not
optimized for research purposes, which resulted in exclusion of some subjects due to a lack of adequate
echocardiographic images. All patients with cirrhosis underwent liver transplantation, but outcome
was not known in all patients due to the hospital informative system that was changed three years ago,
which resulted in a loss of a large amount of data. Therefore, the predictive value of the RV and RA
strain was not possible to determine. Biomarkers related to RV or LV dysfunction were not available
for all patients, which potentially could be helpful to define association between cirrhosis and cardiac
remodeling. Lastly, alcohol by itself could induce cardiac dysfunction and we could not compare
its influence with other etiologies because all our patients were diagnosed for alcoholic end-stage
liver cirrhosis.
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6. Conclusions
The RV structure and mechanics are impaired in patients with end-stage liver cirrhosis preparing
for liver transplantation. The RV strain is reduced for the whole ventricle, but also for the RV-free wall,
which indicates that cirrhosis has an independent effect on the RV. Conventional echocardiographic
parameters of RV systolic function remained unchanged in patients with cirrhosis. RA phasic function
is also impaired in patients with cirrhosis comparing with controls. Using volumetric and strain
analysis of the RA phasic function, we obtained that all functions (reservoir, conduit, and contractile)
are impaired in cirrhotic patients. Further follow-up studies with a larger number of patients are
necessary to establish the predictive value of the RV strain and RA phasic function on the outcome
in patients with end-stage liver cirrhosis.
Author Contributions: M.T. and K.Z. conceived and designed the experiments; A.B., F.V.K., R.B.S. and
E.M.T. performed the experiments; M.T., A.B. and C.C. analyzed the data; R.B.S., and E.M.T. contributed
reagents/materials/analysis tools; M.T. wrote the paper; C.C., F.H. and B.P. revised the paper and provided
significant scientific contribution.
Acknowledgments: We acknowledge support from the German Research Foundation (DFG) and the Open Access
Publication Fund of Charité—Universitätsmedizin Berlin.
Conflicts of Interest: The authors declare no conflict of interest
References
1. Alqahtani, S.A.; Fouad, T.R.; Lee, S.S. Cirrhotic cardiomyopathy. Semin. Liver Dis. 2008, 28, 59–69. [CrossRef]
[PubMed]
2. Wong, F. Cirrhotic cardiomyopathy. Hepatol. Int. 2009, 3, 294–304. [CrossRef] [PubMed]
3. Kazankov, K.; Holland-Fischer, P.; Andersen, N.H.; Torp, P.; Sloth, E.; Aagaard, N.K.; Vilstrup, H. Resting
myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging. Liver Int. 2011, 31, 534–540.
[CrossRef] [PubMed]
4. Sampaio, F.; Pimenta, J.; Bettencourt, N.; Fontes-Carvalho, R.; Silva, A.P.; Valente, J.; Bettencourt, P.;
Fraga, J.; Gama, V. Systolic and diastolic dysfunction in cirrhosis: A tissue-Doppler and speckle tracking
echocardiography study. Liver Int. 2013, 33, 1158–1165. [CrossRef] [PubMed]
5. Zito, C.; Longobardo, L.; Citro, R.; Galderisi, M.; Oreto, L.; Carerj, M.L.; Manganaro, R.; Cusmà-Piccione, M.;
Todaro, M.C.; Di Bella, G.; et al. Ten years of 2D longitudinal strain for early myocardial dysfunction
detection: A clinical overview. Biomed Res. Int. 2018, 2018. [CrossRef] [PubMed]
6. Stanton, T.; Leano, R.; Marwick, T.H. Prediction of all-cause mortality from global longitudinal speckle
strain: Comparison with ejection fraction and wall motion scoring. Circ. Cardiovasc. Imaging 2009, 2, 356–364.
[CrossRef] [PubMed]
7. Ayach, B.; Fine, N.M.; Rudski, L.G. Right ventricular strain: Measurement and clinical application.
Curr. Opin. Cardiol. 2018, 33, 486–492. [CrossRef] [PubMed]
8. Karabay, C.Y.; Kocabay, G.; Kalayci, A.; Colak, Y.; Oduncu, V.; Akgun, T.; Kalkan, S.; Guler, A.; Kirma, C.
Impaired left ventricular mechanics in nonalcoholic fatty liver disease: A speckle-tracking echocardiography
study. Eur. J. Gastroenterol. Hepatol. 2014, 26, 325–331. [CrossRef]
9. Altekin, R.E.; Caglar, B.; Karakas, M.S.; Ozel, D.; Deger, N.; Demir, I. Evaluation of subclinical left ventricular
systolic dysfunction using two-dimensional speckle-tracking echocardiography in patients with non-alcoholic
cirrhosis. Hellenic. J. Cardiol. 2014, 55, 402–410.
10. Zamirian, M.; Samiee, E.; Moaref, A.; Abtahi, F.; Tahamtan, M. Assessment of Subclinical Myocardial Changes
in Non-Alcoholic Fatty Liver Disease: A Case-Control Study using speckle tracking echocardiography.
Iran. J. Med. Sci. 2018, 43, 466–472.
11. Rimbas¸, R.C.; Baldea, S.M.; Guerra, R.D.G.A.; Visoiu, S.I.; Rimbas¸, M.; Pop, C.S.; Vinereanu, D. New definition
criteria of myocardial dysfunction in patients with liver cirrhosis: A speckle tracking and tissue Doppler
imaging study. Ultrasound Med. Biol. 2018, 44, 562–574. [CrossRef] [PubMed]
J. Clin. Med. 2019, 8, 1285 9 of 9
12. Rudski, L.G.; Lai, W.W.; Afilalo, J.; Hua, L.; Handschumacher, M.D.; Chandrasekaran, K.; Solomon, S.D.;
Louie, E.K.; Schiller, N.B. Guidelines for the echocardiographic assessment of the right heart in adults: A report
from the American Society of Echocardiography endorsed by the European Association of Echocardiography,
a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.
J. Am. Soc. Echocardiogr. 2010, 23, 685–713. [PubMed]
13. Lang, R.M.; Badano, L.P.; Mor-Avi, V.; Afilalo, J.; Armstrong, A.; Ernande, L.; Flachskampf, F.A.;
Foster, E.; Goldstein, S.A.; Kuznetsova, T.; et al. Recommendations for cardiac chamber quantification by
echocardiography in adults: An update from the american society of echocardiography and the European
association of cardiovascular imaging. Eur. Heart J. Cardiovasc. Imaging 2015, 16, 233–271. [CrossRef]
[PubMed]
14. Badano, L.P.; Kolias, T.J.; Muraru, D.; Abraham, T.P.; Aurigemma, G.; Edvardsen, T.; D’hooge, J.; Donal, E.;
Fraser, A.G.; Marwick, T.; et al. Standardization of left atrial, right ventricular, and right atrial deformation
imaging using two-dimensional speckle tracking echocardiography: A consensus document of the
EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur. Heart J. Cardiovasc. Imaging 2018,
19, 591–600. [CrossRef] [PubMed]
15. Zakia, E.R.; Baha El Deenb, N.M. Relation of right ventricular dysfunction to the severity of hepatic cirrhosis
by different echo modalities using speckle-tracking echocardiography. Al-Azhar Assiut Med. J. 2017, 15, 7–14.
16. Sunbul, M.; Kivrak, T.; Durmus, E.; Akin, H.; Aydin, Y.; Ergelen, R.; Yilmaz, Y.; Agirbasli, M. Nonalcoholic
steatohepatitis score is an independent predictor of right ventricular dysfunction in patients with nonalcoholic
fatty liver disease. Cardiovasc. Ther. 2015, 33, 294–299. [CrossRef]
17. Sakurai, D.; Asanuma, T.; Masuda, K.; Hioki, A.; Nakatani, S. Myocardial layer-specific analysis of ischemic
memory using speckle tracking echocardiography. Int. J. Cardiovasc. Imaging 2014, 30, 739–748. [CrossRef]
18. Kim, S.A.; Park, S.M.; Kim, M.N.; Shim, W.J. Assessment of left ventricular function by layer-specific strain
and its relationship to structural remodeling in patients with hypertension. Can. J. Cardiol. 2016, 32, 211–216.
[CrossRef]
19. Tadic, M.; Cuspidi, C.; Vukomanovic, V.; Ilic, S.; Obert, P.; Kocijancic, V.; Celic, V. Layer-specific deformation of the
left ventricle in uncomplicated patients with type 2 diabetes and arterial hypertension. Arch. Cardiovasc. Dis. 2018,
111, 17–24. [CrossRef]
20. Tadic, M.; Cuspidi, C.; Vukomanovic, V.; Ilic, S.; Celic, V.; Obert, P.; Kocijancic, V. The influence of type 2
diabetes and arterial hypertension on right ventricular layer-specific mechanics. Acta. Diabetol. 2016, 53,
791–797. [CrossRef]
21. Luong, C.; Thompson, D.J.; Bennett, M.; Gin, K.; Jue, J.; Barnes, M.E.; Colley, P.; Tsang, T.S. Right atrial
volume is superior to left atrial volume for prediction of atrial fibrillation recurrence after direct current
cardioversion. Can. J. Cardiol. 2015, 31, 29–35. [CrossRef] [PubMed]
22. Tadic, M. The right atrium, a forgotten cardiac chamber: An updated review of multimodality imaging.
J. Clin. Ultrasound 2015, 43, 335–345. [CrossRef] [PubMed]
23. Padeletti, M.; Cameli, M.; Lisi, M.; Zacà, V.; Tsioulpas, C.; Bernazzali, S.; Maccherini, M.; Mondillo, S. Right
atrial speckle tracking analysis as novel noninvasive method for pulmonary hemodynamics assessment
in patients with chronic systolic heart failure. Echocardiography 2011, 28, 658–664. [CrossRef] [PubMed]
24. Chayanupatkul, M.; Liangpunsakul, S. Cirrhotic cardiomyopathy: Review of pathophysiology and treatment.
Hepatol. Int. 2014, 8, 308–315. [CrossRef] [PubMed]
25. Yu, H.C.; Burrell, L.M.; Black, M.J.; Wu, L.L.; Dilley, R.J.; Cooper, M.E.; Johnston, C.I. Salt induces myocardial
and renal fibrosis in nor-motensive and hypertensive rats. Circulation 1998, 98, 2621–2628. [CrossRef]
26. Couperus, L.E.; Vliegen, H.W.; Sorgdrager, B.J.; den Dulk, A.C.; Beeres, S.L.M.A.; Sarton, E.Y.; Dubbeld, J.;
Schalij, M.J.; Jukema, J.W.; van Hoek, B.; et al. Prognostic importance of increased right ventricular afterload
in orthotopic liver transplantationrecipients with endstage cirrhosis. Heart Lung Circ. 2019, 28, 893–900.
[CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
